Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma
NCT04274816
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Cutaneous Melanoma
Interventions
DRUG:
Tremelimumab
Sponsor
A.J.M. van den Eertwegh